DOWNERS GROVE, Ill., Feb. 19, 2021 (GLOBE NEWSWIRE) — FAST (Foundation for Angelman Syndrome Therapeutics) and the Simons Foundation Autism Research Initiative (SFARI) today announced a collaboration to launch the International Angelman Syndrome Research Council (INSYNC-AS). Using a robust integrated approach, the Council will evaluate and drive research initiatives in […] Lire la suite »
Sumo Logic Announces Upcoming Conference Participation
REDWOOD CITY, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Sumo Logic, (Nasdaq: SUMO) the pioneer in continuous intelligence, announced today that members of its management team will present at the following investor conferences: The Morgan Stanley Technology, Media and Telecom Conference, March 2nd at 2:00PM Pacific Time, 5:00 PM Eastern […] Lire la suite »
Magna Announces Fourth Quarter 2020 Results and Outlook
Fourth Quarter 2020 Highlights Sales of $10.6 billion increased 12%, compared to higher global light vehicle production of 4% Diluted earnings per share of $2.45, compared to $1.43 in the fourth quarter of 2019 Adjusted diluted earnings per share of $2.83, more than double the fourth quarter of 2019 Cash […] Lire la suite »
Renault a enregistré une perte historique de 8 milliards d’euros en 2020
Les ventes de véhicules ont reculé de 21,3% l’année dernière par rapport à 2019, rapporte le groupe automobile français. Powered by WPeMatico Lire la suite »
Pixium Vision annonce ses résultats annuels 2020 et fait le point sur ses activités
Pixium Vision annonce ses résultats annuels 2020 et fait le point sur ses activités Trésorerie au 31 décembre 2020 : 10,6 millions d’euros Sécurisation de la trésorerie jusqu’à fin 2021 Étude pivot européenne PRIMAvera du Système Prima démarrée au 4e trimestre 2020 Paris, 19 février 2021 – 7h00 CET – Pixium […] Lire la suite »
Pixium Vision announces its financial results for 2020 and provides a business update
Pixium Vision announces its financial results for 2020 and provides a business update Cash position at 31 December 2020: €10.6 million Cash runway to end of 2021 PRIMAvera European pivotal study of Prima System initiated in Q4 2020 Paris, 19 February 2021 – 7.00 a.m. CET – Pixium Vision (FR0011950641 […] Lire la suite »
Junshi Biosciences Announces Acceptance by the NMPA of Supplemental New Drug Application for Toripalimab Combined with Chemotherapy for The First-Line Treatment of Nasopharyngeal Carcinoma
SHANGHAI, China, Feb. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted its supplemental New Drug Application (sNDA) for Toripalimab […] Lire la suite »